Chambal Fertilisers and Chemicals Limited, together with its subsidiaries, produces and sells fertilizers primarily in India. It offers urea; and other agri-inputs, such as di-ammonium phosphate, murate of potash, single super phosphate, and pesticides, as well as NPK fertilizers, specialty fertilizers and micro nutrients, insecticides, fungicides, and herbicides under the Uttam brand. The company was incorporated in 1985 and is headquartered in New Delhi, India.
Revenue projections:
Revenue projections for CHAMBLFERT With CHAMBLFERT's revenue expected to be lower than the previous year, investors may become cautious. Declining revenues often negatively impact the bottom line, reducing profitability and raising concerns among investors about the company's ability to maintain strong financial performance moving forward.
Financial Ratios:
currentRatio
0.000000
forwardPE
15.205357
debtToEquity
1.215000
earningsGrowth
0.208000
revenueGrowth
0.131000
grossMargins
0.430060
operatingMargins
0.141300
trailingEps
40.400000
forwardEps
17.500000
Chambal Fertilisers and Chemicals Limited's Forward PE ratio is favorable, meaning the stock price aligns well with earnings and isn't overvalued. This allows room for growth, making it an attractive investment for those seeking potential upside while ensuring the stock is not overpriced. Positive earnings and revenue growth for CHAMBLFERT suggest that the company is expected to grow its business. This trend reflects strong financial performance, with continued profitability and sales increases indicating a bright outlook for future expansion. Chambal Fertilisers and Chemicals Limited's forward EPS being less than trailing EPS suggests the company may see a drop in profitability this year. This signals potential financial challenges and a less optimistic outlook for earnings growth.
Insider Transactions:
Insider Transactions for CHAMBLFERT
There were 11 CHAMBLFERT sales transactions, at market price of 438.24999445134944.There were 1 transactions to buy CHAMBLFERT stock, with market price of 403.8500061035156.There is no discernible trend in insider transactions, making it hard to determine whether these actions signal positive or negative developments within the company.
Recommendation changes over time:
Recommendations trend for CHAMBLFERT
Analysts have shown a buy bias for CHAMBLFERT, signaling it as a strong investment choice. This positive outlook could motivate investors to allocate funds to CHAMBLFERT, seeing it as a reliable and potentially profitable option, especially in an environment where the stock market is highly scrutinized.
DISCLAIMER: We provide information and our musings based on events, but nothing on this site can be considered professional advice of any kind.
This article examines the recent slowdown in GDP growth to 5.4 percent,...
By clicking "Accept", you agree to the storing of cookies on your device to enhance site navigation, analyze site usage and assist in our tailored marketing efforts.